Results 1 - 10 of 1884

< 1 2 3 ... 188 189 >

• [DOI: 10.1016/j.ejmech.2009.01.026]
  
• Shakeri-Nejad K; Aslanis V; Veldandi UK; Mooney L; Pezous N; Brendani B; Juan A; Allison M; Perry R; Legangneux E. Effects of Therapeutic and Supratherapeutic Doses of Siponimod (BAF312) on Cardiac Repolarization in Healthy Subjects., Clinical therapeutics

  [PubMed: 26519230]
  [DOI: 10.1016/j.clinthera.2015.09.00]
  
• Kubitza D; Mueck W; Becka M. Randomized, double-blind, crossover study to investigate the effect of rivaroxaban on QT-interval prolongation., Drug safety

  [PubMed: 18095747]
  
• Hu KZ; Sun HY; Sui C. Effects of five treatment regimens on blood loss and blood transfusion in total knee arthroplasty: a preliminary study in China?., International journal of clinical pharmacology and therapeutics

  [PubMed: 28139973]
  [DOI: 10.5414/CP202813]
  
• Wang JW; Chen B; Lin PC; Yen SH; Huang CC; Kuo FC. The Efficacy of Combined Use of Rivaroxaban and Tranexamic Acid on Blood Conservation in Minimally Invasive Total Knee Arthroplasty a Double-Blind Randomized, Controlled Trial., The Journal of arthroplasty

  [PubMed: 27663190]
  [DOI: 10.1016/j.arth.2016.08.020]
  
• Musgrave KM; Powell J. A systematic review of anti-thrombotic therapy in epistaxis., Rhinology

  [PubMed: 27591836]
  [DOI: 10.4193/Rhin16.040]
  
• Wood B; Sholzberg M; Ackery A. Direct oral anticoagulants and the bleeding patient., CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

  [PubMed: 26464134]
  [DOI: 10.1503/cmaj.150604]
  
• Utkewicz MD; Brunetti L; Awad NI. Epistaxis complicated by rivaroxaban managed with topical tranexamic acid., The American journal of emergency medicine

  [PubMed: 25895714]
  [DOI: 10.1016/j.ajem.2015.02.049]
  
• Linkins LA; Moffat K. Monitoring the anticoagulant effect after a massive rivaroxaban overdose., Journal of thrombosis and haemostasis : JTH

  [PubMed: 25040104]
  [DOI: 10.1111/jth.12669]
  
• Clav? A; Fazilleau F; Dumser D; Lacroix J. Efficacy of tranexamic acid on blood loss after primary cementless total hip replacement with rivaroxaban thromboprophylaxis: A case-control study in 70 patients., Orthopaedics & traumatology, surgery & research : OTSR

  [PubMed: 22542983]
  [DOI: 10.1016/j.otsr.2011.12.005]